Literature DB >> 15075497

Mood and substance use disorders in older adults with HIV/AIDS: methodological issues and preliminary evidence.

Judith G Rabkin1, Martin C McElhiney, Stephen J Ferrando.   

Abstract

OBJECTIVE: To review methodological issues and available data regarding the prevalence of psychiatric disorders in HIV-positive people over the age of 50 years.
RESULTS: We were unable to find any published data providing prevalence rates of depression and substance use disorders, the most common psychiatric disorders, for HIV-positive adults over 50 years, compared with HIV-seronegative adults over 50 years or HIV-positive adults under the age of 50 years. Epidemiological data from population studies in the United States and internationally consistently show a substantial decline in the rates of depression and substance use disorders with progressive age in the general population. Preliminary data in our small sample suggest that, unlike HIV-seronegative older adults whose rates of disorder decline substantially compared with younger adults, this decline was not observed for older HIV-positive adults.
CONCLUSION: Given the relative infrequency of disorder and the need to control both for age and HIV status, a large-scale study with four groups is required: HIV-positive men and women under and over 50 years of age, and HIV-negative men and women under and over 50 years of age.

Entities:  

Mesh:

Year:  2004        PMID: 15075497

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  37 in total

1.  Challenges in addressing depression in HIV research: assessment, cultural context, and methods.

Authors:  Jane M Simoni; Steven A Safren; Lisa E Manhart; Karen Lyda; Cynthia I Grossman; Deepa Rao; Matthew J Mimiaga; Frank Y Wong; Sheryl L Catz; Michael B Blank; Ralph DiClemente; Ira B Wilson
Journal:  AIDS Behav       Date:  2011-02

Review 2.  Neuropsychiatric complications of aging with HIV.

Authors:  Crystal C Watkins; Glenn J Treisman
Journal:  J Neurovirol       Date:  2012-05-30       Impact factor: 2.643

3.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

4.  Syndemic Profiles and Sexual Minority Men's HIV-Risk Behavior: A Latent Class Analysis.

Authors:  Jillian R Scheer; Kirsty A Clark; Anthony J Maiolatesi; John E Pachankis
Journal:  Arch Sex Behav       Date:  2021-01-22

Review 5.  Substance use: impact on adherence and HIV medical treatment.

Authors:  Adam Gonzalez; Jennifer Barinas; Conall O'Cleirigh
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

6.  Coping styles and illicit drug use in older adults with HIV/AIDS.

Authors:  Linda M Skalski; Kathleen J Sikkema; Timothy G Heckman; Christina S Meade
Journal:  Psychol Addict Behav       Date:  2013-02-25

7.  Depression and aging with HIV: Associations with health-related quality of life and positive psychological factors.

Authors:  Alexandra S Rooney; Raeanne C Moore; Emily W Paolillo; Ben Gouaux; Anya Umlauf; Scott L Letendre; Dilip V Jeste; David J Moore
Journal:  J Affect Disord       Date:  2019-03-06       Impact factor: 4.839

Review 8.  Affective disorders in patients with HIV infection: impact of antiretroviral therapy.

Authors:  Gabriele Arendt
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

9.  Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States.

Authors:  Bryan Hartzler; Julia C Dombrowski; Heidi M Crane; Joseph J Eron; Elvin H Geng; W Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan
Journal:  AIDS Behav       Date:  2017-04

10.  Update on mental health issues in patients with HIV infection.

Authors:  Natalia Vlassova; Andrew F Angelino; Glenn J Treisman
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.